Intelligence · Clinical Pipeline
S.L Pipeline
All ClinicalTrials.gov programs at S.L — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
S.L has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
CBP-174
S.L
Healthy Adult Subjects
1 trial -
CBP-307
S.L
Autoimmune Diseases
2 trials -
CBP-307
S.L
Healthy Adult Subjects
1 trial -
Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
S.L
STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder
1 trial -
Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
S.L
Healthy Adult Subjects
1 trial -
vitamin D3
S.L
X-linked Adrenoleukodystrophy
1 trial
Frequently asked questions
How many pipeline programs does S.L have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs